Table 3. Tumor response evaluation by mRECIST.
| MRECIST criteria | TACE + sorafenib |
TACE | χ2 | P |
|---|---|---|---|---|
| CR, n (%) | 2 (1.94) | 0 (0.00) | ||
| PR, n (%) | 67 (65.05) | 55 (41.35) | 15.300 | 0.0001 |
| SD, n (%) | 28 (27.18) | 68 (51.13) | ||
| PD, n (%) | 6 (5.83) | 10 (7.52) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.